Key facts
- Delorean AI’s last known valuation is $59.5M (Aug 2023).
- It has raised $11.4M; the latest was PE Growth/Expansion ($440K) in Dec 2024.
- Notable investors include Tampa Bay Wave, Mindful Venture Capital, Pinta Capital Partners, Sopris Venture Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for Delorean AI
- ·The full record, as it builds
Funding rounds
No funding rounds for Delorean AI are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Delorean AI
Developer of an artificial intelligence-based predictive system designed for unmitigated disease escalation. The company's system can recognize that a future event with a given probability will happen and how to intervene, whether it be to enhance a good outcome or mitigate a negative impact, enabling medical companies to build sentient systems of intelligence to address business challenges.
- Sector
- Healthcare
- HQ
- Palm Beach, FL, United States
- Founded
- 2019
- Employees
- 25
- Website
- deloreanai.com/
- Ownership
- Privately Held (backing)
Delorean AI doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Delorean AI shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Delorean AI in its N-PORT filings yet. We sweep new filings monthly.